Amide Technologies offers on-demand complex peptide manufacturing at unprecedented speed. Through its novel manufacturing platform developed at MIT, Amide is bridging the gap between traditional solid phase peptide synthesis and biological expression, empowering scientists on the cutting edge of peptide drug design.
| Website | https://www.amidetech.com/ |
| Employees | 16 (12 on RocketReach) |
| Founded | 2017 |
| Address | 750 Main St Ste 308, Cambridge, Massachusetts 02139, US |
| Technologies |
JavaScript
,
HTML
,
Twitter
+8 more
(view full list)
|
| Industry | Biotechnology |
| Keywords | Peptide Synthesis, Custom Peptide Manufacturing, On Demand Manufacturing, Biopharmaceutical Manufacturing, Pharmaceutical Peptides, Drug Development, Biotechnology, Protein Synthesis, Synthetic Peptides, Peptide Api |
| Competitors | Maximus, Apex Systems, Pyramid Consulting, Inc, Manhattan Associates, Innova Solutions, TechFlow, Inc., Fuse by Catapult Systems, Clarity Innovations, Inc., ByteCubed Ventures, PGSC (acquired by Booz Allen) +45 more (view full list) |
Looking for a particular Amide Technologies employee's phone or email?
Philip Dixon is the COO of Amide Technologies.
12 people are employed at Amide Technologies.
Amide Technologies is based in Cambridge, Massachusetts.